The new guidelines describe the features of chronic pulmonary aspergillosis (CPA) and provide comprehensive treatment recommendations.
Researchers designed a case-control study using de-identified commercial health claim information in the United States from January 1, 2007, to December 31, 2009.
Treatment was tested in critically ill patients with ICU-acquired sepsis, multiple Candida colonization, and multiple organ failure.
Flu may represent a novel host risk factor for this invasive fungal infection.
The updated guidelines focus on the diagnosis and treatment of the major forms of aspergillosis: allergic, chronic and invasive, the latter which kills 40% to 80% of those with widespread infection.
Drs Tapper and Crum-Cianflone discuss aspergillosis, an emerging complication of severe influenza infections.
Rapid identification of Candida auris is crucial in order to implement appropriate precautions and avoid transmission to other patients.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Clinicians Warn That Zika Virus May Still Be an Area of Concern for Travelers
- Inappropriate Prescribing of Antibiotics High in Urgent Care Centers
- Fixed-Dose Bictegravir Regimen: A Safe Alternative in Adults With HIV-1
- Point-Counterpoint: Should We Implement Needle Exchange Programs for the Prevention of Hepatitis C Virus?
- FDA: Vibrio parahaemolyticus Illnesses Tied to Fresh Crab Meat From Venezuela
- Universal Purchase Programs in the United States May Not Effectively Increase Vaccination Rates
- Tick-Caused Meat Allergy on the Rise in the United States
- Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients
- Sofosbuvir/Velpatavir Effective for HCV-Infected Liver Transplant Recipients
- Should Metronidazole Be Recommended for Mild Clostridium difficile Infections?
- Same-Day ART Initiation in HIV+ Pregnant Women Does Not Worsen Outcomes
- Novel Nanodiagnostic Panel May Reduce Empiric Antifungal Use in High-Risk Candidemia
- Antimicrobial Lock Solutions Are Cost-Effective for Preventing Central Line-Associated Bloodstream Infections
- Predictors of Influenza Vaccine Acceptance in Inflammatory Rheumatic Diseases
- Pegylated Interferon, Ribavirin May Improve LV Diastolic Dysfunction in Chronic Hepatitis C